Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Episode 26 • December 07, 2022 • 00:39:02
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
Few & Far Between: How Biotech Gets Built
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Dec 07 2022 | 00:39:02

/

Show Notes

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

Other Episodes

Episode 20

May 18, 2022 • 00:30:43
Episode Cover

Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

What do the next 100 years have in store for healthcare and clinical research? Biorasi's Few & Far Between podcast welcomes Professor Bertil E....

Listen

Episode 72

June 22, 2026 • 00:52:44
Episode Cover

Episode 72: Joel White, Owner, Marketcap Consulting

Today on the Biorasi Few & Far Between podcast: What's trending in the CRO market? Find out as host Melissa Alesse welcomes Joel White,...

Listen

Episode 59

September 03, 2025 • 00:43:41
Episode Cover

Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host...

Listen